QuadMedicine Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-8,129	-6,931	-4,968	-9,759
Depreciation & Amortization	3,448	3,296	3,153	2,071
Loss (Gain) From Sale of Assets	16.34	16.34	-	-
Stock-Based Compensation	187.99	281.42	608.42	1,456
Other Operating Activities	-183.09	-69.88	-128.87	40.43
Change in Accounts Receivable	-3.63	-706.73	-1,082	-6.41
Change in Other Net Operating Assets	348.6	-433.43	3,490	7,957
Operating Cash Flow	-4,315	-4,547	1,072	1,760
Operating Cash Flow Growth	-	-	-39.09%	-
Capital Expenditures	-2,342	-2,191	-3,286	-11,817
Sale (Purchase) of Intangibles	-219.08	-224.45	-218.8	-95.1
Investment in Securities	-12,500	-1,000	-10	4,760
Other Investing Activities	-135.8	-120.28	66.23	-134.66
Investing Cash Flow	-15,974	-4,313	-3,449	-7,286
Short-Term Debt Issued	-	-	500	-
Long-Term Debt Issued	-	-	800	5,800
Total Debt Issued	-	-	1,300	5,800
Long-Term Debt Repaid	-	-357.49	-313.44	-271.52
Net Debt Issued (Repaid)	-372.11	-357.49	986.56	5,528
Issuance of Common Stock	26,360	25,789	7,000	537.1
Other Financing Activities	-	-	74.04	196.28
Financing Cash Flow	25,987	25,431	8,061	6,262
Foreign Exchange Rate Adjustments	152.83	-327.15	129.9	20.89
Net Cash Flow	5,851	16,244	5,814	757.16
Free Cash Flow	-6,657	-6,738	-2,214	-10,056
Free Cash Flow Margin	-68.05%	-62.98%	-23.80%	-993.97%
Free Cash Flow Per Share	-653.19	-701.66	-253.98	-1164.44
Cash Interest Paid	348.07	352.04	368.76	64.9
Cash Income Tax Paid	5.12	9.25	-17.81	4.46
Levered Free Cash Flow	-5,647	-6,805	-2,182	-
Unlevered Free Cash Flow	-5,435	-6,587	-1,951	-
Change in Working Capital	344.97	-1,140	2,408	7,951